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Background. The Kassena-Nankana District (KND) of northern Ghana lies in the African meningitis belt, where
epidemics of bacterial meningitis have been reoccurring every 8–12 years. These epidemics are generally caused by
Neisseria meningitidis, an organism that is considered to be uniquely capable of causing meningitis epidemics.
Methods. We recruited all patients with suspected meningitis in the KND between 1998 and 2003. Cerebro-
spinal fluid samples were collected and analyzed by standard microbiological techniques. Bacterial isolates were
subjected to serotyping, multilocus sequence typing (MLST), and antibiotic-resistance testing.
Results. A continual increase in the incidence of pneumococcal meningitis was observed from 2000 to 2003.
This outbreak exhibited strong seasonality, a broad host age range, and clonal dominance, all of which are char-
acteristic of meningococcal meningitis epidemics in the African meningitis belt. The case-fatality rate for pneu-
mococcal meningitis was 44.4%; the majority of pneumococcal isolates were antibiotic sensitive and expressed the
serotype 1 capsule. MLST revealed that these isolates belonged to a clonal complex dominated by sequence type
(ST) 217 and its 2 single-locus variants, ST303 and ST612.
Conclusions. The S. pneumoniae ST217 clonal complex represents a hypervirulent lineage with a high pro-
pensity to cause meningitis, and our results suggest that this lineage might have the potential to cause an epidemic.
Serotype 1 is not included in the currently licensed pediatric heptavalent pneumococcal vaccine. Mass vaccination
with a less complex conjugate vaccine that targets hypervirulent serotypes should, therefore, be considered.
Neisseria meningitidis, Streptococcus pneumoniae, and
Haemophilus influenzae type b (Hib) are the most com-
mon causes of acute bacterial meningitis [1]. Meningitis
caused by N. meningitidis has been considered to be
unique with respect to its epidemic occurrence. A re-
gion of sub-Saharan Africa extending from Ethiopia to
Senegal, designated “the African meningitis belt,” has
been particularly vulnerable to meningococcal disease
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epidemics. In addition to sporadic disease, which oc-
curs mainly during the annual dry season, epidemics
have occurred in the African meningitis belt every 8–
12 years over the past 100 years [2, 3].
Information on the epidemiologic profile of pneu-
mococcal meningitis in the African meningitis belt is
fragmentary, but some studies have found S. pneumo-
niae to be the most important causative agent of bac-
terial meningitis in certain areas [4]. The incidence in
these areas is 10–20 cases/100,000 people/year, which
is ∼10 times higher than that in western Europe and
the United States [5, 6]. Cases of S. pneumoniae men-
ingitis occur throughout the year, and most studies re-
port the youngest (!2 years) and the oldest (160 years)
people to be at greatest risk [4, 5]. For unknown rea-
sons, the case-fatality rate for pneumococcal meningitis
(∼50%) is 5–10 times higher than that for meningo-
coccal meningitis.
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Figure 1. No. of laboratory-confirmed (by culture and/or latex agglu-
tination assay) meningitis cases in the Kassena-Nankana District of north-
ern Ghana between 1998 and 2003. No laboratory data were available
on the patients with suspected meningitis that was diagnosed during the
wet season of 1998–1999. , Neisseria meningitidis; , Streptococcus
pneumoniae; , Haemophilus influenzae type b.
Although there are ∼90 known pneumococcal serotypes, only
a limited number account for most of the invasive infections.
The serotype distribution varies with time, location, and age
group [6]. Clonal dominance and global spread has been de-
scribed for a small number of highly successful drug-resistant
(and often multidrug-resistant) pneumococcal clones [7]. Se-
rotype 1 is one of the most common serotypes that cause in-
vasive disease worldwide, particularly in Africa [6, 8, 9]. It has
a high attack rate but is rarely isolated from healthy carriers
or from people with mild occult bacteremia. Outbreaks of in-
vasive serotype 1 pneumococcal disease have occurred in several
communities [4, 6, 10–14].
The present study was conducted between 1998 and 2003 in
the Kassena-Nankana District (KND) of northern Ghana. After
a large meningococcal meningitis epidemic occurred during the
dry season of 1997, all patients with suspected meningitis were
recruited prospectively. Cerebrospinal fluid (CSF) samples were
collected and analyzed by standard microbiological techniques.
Between 2000 and 2003, a continuous increase in the incidence
of pneumococcal meningitis was observed. Here, we demon-
strate that the epidemiological and bacteriological features of
this outbreak closely resemble those usually associated with me-
ningococcal meningitis epidemics, and the implications of these
observations with respect to the control of bacterial meningitis
in the African meningitis belt are discussed.
PATIENTS, MATERIALS, AND METHODS
Study area. The KND has a population of 140,000 and lies
within the Guinea savanna woodland area of northern Ghana.
Two major seasons exist, a short wet season from May to Oc-
tober and a long dry season for the remainder of the year. The
general population is rural, except for those living in the town
of Navrongo, which has a population of 20,000. People live in
compounds with an average of 10 inhabitants.
Patients. CSF samples were collected between January 1998
and December 2003 from patients with suspected meningitis
who reported to the War Memorial Hospital in Navrongo or
to 1 of 4 health centers in the KND. In line with Ghana’s stan-
dard diagnostic procedures, samples were analyzed at the lab-
oratory of the War Memorial Hospital, for confirmation of the
clinical diagnosis. Additional samples were obtained from the
Bolgatanga Regional Hospital in the Upper East Region and
from health facilities in the Bongo and Builsa Districts. In 1998–
1999, only samples collected during the dry season were ana-
lyzed. Thereafter, samples collected from the few patients with
suspected meningitis who presented during the wet season were
also included. Ethical clearance for the study was obtained from
the responsible institutional review boards and the Ghanaian
Ministry of Health. Clinical and demographic information was
recorded for all patients. Personal data were linked with the
database of the Navrongo Demographic Surveillance System
(NDSS). The denominators used for calculation of incidence
rates represent the average annual population of the KND be-
tween 1995 and 1999 [15].
Analysis of CSF samples. CSF samples were analyzed by
direct staining with Gram stain. Boiled CSF supernatants were
tested serologically for capsular polysaccharide antigens of N.
meningitidis (serogroups A, B, C, and W135), S. pneumoniae,
and Hib (Slidex Meningite Kit, bioMe´rieux; Pasteurex Kit, Bio-
Rad). CSF samples were inoculated onto blood, chocolate, and
Thayer Martin agar and then incubated in candle jars for 24
h at 37C. S. pneumoniae colonies were identified on the basis
of colony morphological structure, Gram-stain behavior, and
resistance to optochin (Taxo P discs, BD). All pneumococcal
isolates were serotyped on the basis of the Quellung reaction,
with antisera from the Statens Serum Institute (Copenhagen).
Antibiotic resistance testing. All isolates from the KND were
tested for resistance to penicillin G and chloramphenicol (the 2
antibiotics commonly used in standard therapy for bacterial
meningitis in Ghana) as well as cefotaxime and ciprofloxacin,
by use of E-test strips (Diagnostic Medical Distribution) [16].
The breakpoints of the NCCLS protocol were applied. For cip-
rofloxacin, 4 mg/mL was taken as the breakpoint for resistance
[17]. The ATCC 49619 strain was included as control.
Multilocus sequence typing (MLST). Bacteria were grown
overnight in Todd-Hewitt medium. DNA extraction [18], MLST
[19], and direct sequencing of polymerase chain reaction prod-
ucts by use of an ABI Prism 310 genetic analysis system was
performed in accordance with standard protocols. Allelic pro-
files were analyzed by use of applications on the MLST home
page (available at: http://spneumoniae.mlst.net/). For analysis
of the relationships between closely related isolates, eBURST
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Figure 2. Seasonal patterns of rainfall and no. of laboratory-confirmed (by culture and/or latex agglutination assay) pneumococcal and meningococcal
meningitis cases in the Kassena-Nankana District (KND) of northern Ghana. Data on total monthly rainfall (indicated by shaded areas) are from the
meteorological station of the KND. , Neisseria meningitidis; , Streptococcus pneumoniae.
Figure 3. Incidence of meningococcal (gray bars) and pneumococcal (black bars) meningitis in the Kassena-Nankana District of northern Ghana,
by age. Cases were laboratory confirmed by culture and/or latex agglutination assay.
software (available at: http://eburst.mlst.net/) with the most-
stringent group definition (6/7 alleles identical) was used. All
allelic profiles obtained were compared with the complete list-
ing of the sequence types (STs) available in the database.
RESULTS
Meningitis cases. Between 1998 and 2003, a total of 140 me-
ningococcal, 117 pneumococcal, and 14 Hib meningitis cases
were confirmed by culture and/or latex agglutination assay in
the KND. The number of pneumococcal meningitis cases re-
mained low during the first 2 years of the study but increased
continuously during the following years (figure 1). Two subse-
quent outbreaks of serogroup A meningococcal infection were
reported during the study period. After a large meningococcal
meningitis epidemic occurred in Ghana in 1997, 50 confirmed
serogroup A meningococcal meningitis cases occurred in 1998
[20]. After 2 years of absence, from 2001 onward, serogroup A
meningococcal meningitis cases reemerged, causing annual out-
breaks until 2004 (authors’ unpublished data). The number of
Hib meningitis cases remained low throughout the study period
and mainly occurred in children !7 years old (figure 1).
The vast majority of meningococcal and pneumococcal
meningitis cases occurred during the dry season (figure 2).
The pneumococcal meningitis cases peaked 1–2 months ear-
lier than the meningococcal cases. During the remainder of
the year, only sporadic meningitis cases, mostly caused by S.
pneumoniae, were observed.
Both the patients with meningococcal meningitis and the pa-
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Table 1. Host age distribution of serotype 1 and non–serotype 1 Streptococcus pneumoniae isolates from the Kassena-Nankana




















Serotype 1 isolates 0 2 24 11 11 5 5 58 0.75–72 (15)
Non–serotype 1 isolates 2 2 5 1 3 4 1 18 0.33–85 (13)
Total 2 4 29 12 14 9 6 76 0.33–85 (14)
Serotype(s) of non-1 isolates 14a 3a 3,a 7F, 8, and 12F 8 6A, 8, and 10F 8, 12F, 14, and 38 2 … …
NOTE. Data are no. of isolates, unless otherwise noted. NS, age not specified.
a Two isolates.
tients with pneumococcal meningitis exhibited a broad age range
(figure 3). Infants (!1 year old) had the highest incidence for
both pneumococcal and meningococcal meningitis (43 cases/
100,000 people/year, for both). For pneumococcal meningitis,
the incidences in all other age groups were 15–26 cases/100,000
people/year. For meningococcal meningitis, the incidences were
comparable for children of all age groups and decreased steadily
for the older age groups. As a result, in the patients 160 years
old, the incidence of pneumococcal meningitis was significantly
higher than the incidence of meningococcal meningitis (2.6 vs.
23.4 cases/100,000 people/year). The overall case-fatality rates
were 43.6% (51/117) and 4.3% (6/140) for pneumococcal and
meningococcal meningitis, respectively.
The geographic locations of the homes of 74 patients with
pneumococcal meningitis and 102 patients with meningococcal
meningitis were mapped by use of the NDSS, but neither pneu-
mococcal nor meningococcal cases were geographically clus-
tered (data not shown). Furthermore, no significant family clus-
tering was observed.
Characterization of pneumococcal isolates. Between 1998
and 2003, 76 pneumococcal isolates were obtained from patients
with meningitis in the KND. Fifty-eight (76%) of these belonged
to serotype 1, which was the dominant serotype through-
out the study (table 1). The 18 non–serotype 1 isolates belonged
to 9 different serotypes. Only 33% (2/6) of the isolates from
infants and children 4 years old belonged to serotype 1; the
remainder belonged to serotypes 3 and 14. In contrast, in older
children (5–14 years), young adults (15–29 years), and grown-
ups (30–59 years), the proportions of isolates that belonged to
serotype 1 were 180% (24/29, 11/12, and 11/14, respectively).
In patients 160 years old, the proportion of isolates that be-
longed to serotype 1 was 56% (5/9).
Antibiotic-resistance testing showed that all but 2 of the 58
serotype 1 strains from the KND were completely susceptible
to penicillin G, cefotaxime, chloramphenicol, and ciprofloxa-
cin. The MICs for the 2 strains (both isolated in 2002) with
antibiotic resistances were determined. For strain P1036, the
MICs were as follows: penicillin G, 0.5 mg/mL (intermediate);
cefotaxime, 2 mg/mL (resistant); and chloramphenicol, 5 mg/
mL (intermediate). For strain P1037, the MICs were as follows:
penicillin G, 0.5 mg/mL (intermediate); cefotaxime, 1 mg/mL (in-
termediate); and chloramphenicol, 8 mg/mL (resistant).
All isolates from the KND and 15 isolates from neighboring
districts were analyzed by MLST. The results showed that all
serotype 1 isolates were clonally related (table 2). Ten distinct
STs were identified, but they all shared at least 6 of 7 alleles
with one other ST. ST217 and its 2 single-locus variants, ST303
and ST612, were dominant. In addition, single-locus variants
of the 3 dominant STs were sporadically found. All isolates ob-
tained in 1998 and 2000 had ST217. ST303 isolates were dom-
inant from 2001 onward (6/15 in 2001, 9/18 in 2002, and 14/
20 in 2003).
An eBURST analysis that included the STs of the Ghanaian
strains and all strains available in the MLST database was per-
formed (figure 4). Three of the 10 STs found in the Ghanaian
isolates (ST217, ST303, and ST612) have been previously de-
scribed in 34 serotype 1 lineage B isolates [9]; 16 of these isolates
came from Africa, and the others came from either Israel, Eu-
rope, or the United States. In addition, Brueggemann et al. [9]
defined 3 lineage B–associated STs (ST613, ST614, and ST618),
represented by 4 African isolates and 1 European isolate. The
eBURST diagram demonstrates that all Ghanaian serotype 1
strains found in the present study and all the lineage B isolates
described by Brueggemann et al. are part of a single clonal
complex in which all isolates share 100% genetic identity at 6
or 7 MLST housekeeping loci with at least 1 other member of
the group.
Of the non–serotype 1 isolates, only the serotype 14 isolates
exhibited allelic profiles that were closely related to those of
the serotype 1 clonal complex (table 2). One of the serotype 14
isolates (ST1324) was a single-locus variant of ST1323 (shown
in figure 4), 2 of the serotype 14 isolates (ST1314 and ST1315)
were double-locus variants of ST1323, and the remaining sero-
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Origin (district)aaroE gdh gki recP spi xpt ddl
Serotype 1 217 15 1998–2003 10 18 4 1 7 19 9 KND (13), Bongo (1), and Builsa (1)
612 8 2001–2003 10 18 4 1 7 19 31 KND (7) and Bolgatanga (1)
303 36 2001–2003 10 5 4 1 7 19 9 KND (29) and Bolgatanga (7)
1322 1 2001 10 5 4 1 7 19 31 KND
1316 1 2002 2 18 4 1 7 19 9 KND
1325 2 2002 10 8 4 1 7 19 9 KND
1331 2 2002 13 8 4 1 7 19 9 KND
1327 1 2003 10 18 4 1 13 19 31 KND
1328 1 2003 10 18 4 1 7 21 31 KND
1323 1 2003 10 5 4 1 7 21 9 KND
Serotype 2 74 1 1998 2 13 4 1 6 6 14 KND
Serotype 3 458 7 2001 2 32 9 47 6 21 17 KND (3) and Bolgatanga (4)
Serotype 4 1321 1 2002 8 8 47 18 46 122 31 Bolgatanga
Serotype 6A 1320 1 2002 7 13 8 6 6 8 8 KND
Serotype 7F 1326 1 2002 10 16 4 1 6 21 9 KND
Serotype 8 1317 1 2003 7 5 15 11 83 58 70 KND
1318 1 2000 7 9 15 11 83 58 70 KND
1335 1 2003 7 9 4 60 83 28 70 KND
1319 1 2003 7 9 15 11 83 25 70 KND
Serotype 10F 909 1 2003 2 42 2 1 6 19 20 KND
Serotype 12F 989 1 2003 12 5 89 8 6 112 14 KND
1330 1 2003 12 5 89 8 13 112 14 KND
Serotype 14 1324 1 2002 10 5 4 17 7 21 9 KND
1313 1 2003 2 5 4 12 7 21 14 KND
1315 1 2003 2 5 9 1 7 21 9 KND
1314 1 2003 2 5 4 1 7 21 14 Builsa
Serotype 38 1329 1 2003 12 5 4 10 42 49 9 KND
NOTE. KND, Kassena-Nankana District.
a Values in parentheses indicate the no. of isolates found in each district (given only for those isolates found in 11 district).
type 14 isolate (ST1313) shared 5 alleles with ST1314 and 4 alleles
with ST1323.
DISCUSSION
N. meningitidis is considered to be uniquely capable of causing
bacterial meningitis epidemics. Our observation of a meningi-
tis outbreak caused by S. pneumoniae in the KND of northern
Ghana is, therefore, intriguing. The outbreak exhibited epi-
demiological and bacteriological features that are characteristic
of African meningococcal meningitis epidemics [2], including
strong seasonality, a broad host age range, and clonal domi-
nance. The increase in pneumococcal meningitis cases was ac-
companied by 2 successive outbreaks of meningococcal men-
ingitis. In the KND, the burden of disease for pneumococcal
meningitis has met the criterion for the alert status included
in the World Health Organization’s definition of epidemic me-
ningococcal outbreaks (a threshold of 5 cases/100,000 persons/
week); in the neighboring Bolgatanga District, even the criterion
for the epidemic status (a threshold of 10 cases/100,000 per-
sons/week) has been fulfilled, in March 2001. Cases of both me-
ningococcal and pneumococcal meningitis were concentrated
in the dry season, suggesting that similar factors might have
triggered both types of outbreaks. Such factors may include
mucosal defenses damaged by the extreme environmental con-
ditions and/or coinfections of the nasopharynx [2]. Care was
taken to avoid a bias associated with the well-known seasonality
of meningococcal meningitis in the study area: to account for
the fact that lumbar punctures were less likely to be performed
during the wet season, standardized guidelines for lumbar
puncture were applied.
Interestingly, the pneumococcal meningitis cases peaked 1–
2 months earlier than the meningococcal meningitis cases. This
finding may either (1) reflect a very high invasive capacity of
the causative clonal complex of serotype 1 pneumococci or (2)
indicate that the factors that trigger pneumococcal and me-
ningococcal meningitis are not entirely the same. In this con-
text, differences in climatic conditions between the early dry
season (which includes the Harmattan period, with its cold nights
and extremely dusty air) and the late dry season (which brings
intense heat) may be relevant. The broad host age range for
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Figure 4. e-BURST diagram of the sequence type (ST) 217 clonal complex. Included are all Ghanaian serotype 1 Streptococcus pneumoniae isolates
and 1 Ghanaian serotype 14 S. pneumoniae isolate from the present study as well as all serotype 1 lineage B S. pneumoniae isolates described by
Brueggemann et al. [9]. Lines connect all single-locus variants with each other. Black circles indicate STs found in northern Ghana in the present
study, and the no. of isolates found are given. Gray circles indicate serotype 1 lineage B–associated STs not found in northern Ghana [9], and the
countries of origin of the isolates are given. Shown is a modification of the original diagram produced by e-BURST, which was edited for the no. of
isolates, the origin of non-Ghanaian isolates, and multiple single-locus variant connections.
both meningococcal and pneumococcal meningitis cases shows
that age-related differences in the capacity of natural and adap-
tive immune effector functions are less important for suscep-
tibility to invasive disease than for other epidemiological sit-
uations. Lack of spatial clustering suggests that colonization
with serotype 1 pneumococci is not focal.
Clonally related bacteria from a common epidemiological
source often show limited genotypic variation [21]. Groups of
frequent genotypes plus their epidemiologically associated de-
scendents have been designated “clonal complexes” [21] or “ge-
noclouds” [22], which are determined on the basis of a thresh-
old level of MLST allelic identity. The pneumococcal meningitis
outbreak in the KND was caused by a serotype 1 clonal com-
plex. The 3 most frequently found STs (ST217 and its 2 single-
locus variants, ST303 and ST612) have been described previ-
ously [9], indicating that these genetic variants evolved before
the outbreak in the KND. However, some of the infrequently
isolated locus variants, such as ST1316, ST1322, ST1327, and
ST1328, may have emerged locally. It is interesting to note that
ST1331 and ST1325, which were each found twice in the Gha-
naian isolates, link an ST618 isolate from The Netherlands with
the clonal complex.
Serotype 1 pneumococci are a common cause of invasive
disease in many parts of the world but are found only rarely
in healthy carriers [6, 9, 23]. Studies comparing the prevalences
of S. pneumoniae subgroups in persons with invasive disease
and in healthy carriers showed that individual serotypes may
differ more than 100-fold in their potential to cause invasive
disease [23, 24]. Individual clonal complexes that belong to the
same serotype have different abilities to cause invasive disease
[23], suggesting that clonal complex–specific virulence deter-
minants might be important as well. It is not clear whether the
virulence of the 3 major subgroups of serotype 1 pneumococci
(which have distinct geographic distributions [9, 25]) is deter-
mined primarily by the capsular serotype—and is, therefore,
uniform—or whether lineage-specific genetic differences mod-
ulate the potential to cause particular types of invasive disease.
Our results suggest that the ST217 clonal complex might have
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a particular propensity to cause meningitis. However, more
studies are needed to verify whether this observation is reflective
of a true bacterial phenotype or is merely the result of host
and/or environmental factors.
We do not know whether the ST217 clonal complex was im-
ported into northern Ghana recently or whether it has been
present for a longer period of time without causing more than
sporadic disease. Clonal dissemination of S. pneumoniae is usually
associated with antibiotic resistance [7], but we observed no
significant resistance in the Ghanaian isolates. Therefore, other
factors must have led to the increased incidence of pneumococcal
meningitis in the KND. Vaccination against S. pneumoniae is
uncommon in Ghana. However, the massive immunization cam-
paigns with a meningococcal A plus C carbohydrate vaccine that
were repeatedly conducted throughout the study period might
have played a role. S. pneumoniae and N. meningitidis both col-
onize the human nasopharynx, and effective interventionsagainst
one of these bacteria is likely to promote competing microor-
ganisms. Vaccination with conjugate vaccines has been shown to
reduce nasopharyngeal carriage of the bacterial types included
in the vaccine and to lead to replacement by bacterial types not
included in the vaccine [26, 27]. Even though polysaccharide
vaccines, such as the unconjugated meningococcal A plus C car-
bohydrate vaccine used in the KND, are generally thought to
not affect the prevalence of nasopharyngeal carriage [2], repeated
immunization against N. meningitis still might modify the bac-
terial flora of the nasopharynx [28]. Thus, it is conceivable that
the increase in pneumococcal meningitis in the KND, as well as
the recently observed outbreaks of non–serogroup A and non–
serogroup C meningococcal meningitis [29–31], may have been
promoted by mass vaccination against N. meningitis. It will be
important to investigate the interactions between these bacteria
more closely, especially in the context of vaccination [32].
Serotype 1 is not included in the currently licensed pediatric
heptavalent pneumococcal vaccine. This vaccine contains poly-
saccharides from the 7 serotypes (4, 6B, 9V, 14, 18C, 19F, and
23F) that cause 185% of severe pneumococcal infections in
infants and young children in the United States and Canada
[6, 26]. The vaccine covers 70% of pediatric isolates from Eu-
rope but only 67% and 43% of those from Africa and Asia,
respectively [6]. In the KND, serotypes 3, 7F, 8, 12, and 14
accounted for the non–serotype 1 pneumococcal meningitis
cases in patients !15 years of age. Excepting serotype 1, the
so-called pediatric serotypes (e.g., 1, 5, 6, 9, and 14) [33] were
either not found at all or found only rarely. In the present
study, the pediatric heptavalent conjugate vaccine would have
covered 6% (2/35) of all pneumococcal meningitis cases and
22% (2/9) of the non–serotype 1 pneumococcal meningitis cases
in this age group. A nonavalent conjugate vaccine that includes
serotype 1 is currently being developed, but such a complex
conjugate vaccine may be too expensive for use in mass im-
munization in the African meningitis belt. However, mass vac-
cination with a less complex conjugate vaccine that targets hy-
pervirulent serotypes should be considered, because increased
incidences of pneumococcal meningitis have also been observed
in other districts of Ghana (data not shown). Serotype 1 dom-
inance and a broad host age range also seem to be features of
the current pneumococcal meningitis situation in Burkina Faso
[34, 35]. In view of the high case-fatality rate of pneumococcal
meningitis, there is an urgent need for improved treatment op-
tions that are suitable for countries with limited resources as well.
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